Empirical Finance’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $546K | Buy |
2,497
+21
| +0.8% | +$4.6K | 0.03% | 410 |
|
|
2025
Q1 | $554K | Buy |
2,476
+80
| +3% | +$17.9K | 0.03% | 389 |
|
|
2024
Q4 | $785K | Sell |
2,396
-20
| -0.8% | -$6.55K | 0.05% | 317 |
|
|
2024
Q3 | $725K | Buy |
2,416
+57
| +2% | +$17.1K | 0.04% | 339 |
|
|
2024
Q2 | $777K | Sell |
2,359
-147
| -6% | -$48.4K | 0.05% | 313 |
|
|
2024
Q1 | $992K | Buy |
2,506
+89
| +4% | +$35.2K | 0.06% | 277 |
|
|
2023
Q4 | $851K | Buy |
2,417
+23
| +1% | +$8.1K | 0.06% | 288 |
|
|
2023
Q3 | $898K | Buy |
2,394
+236
| +11% | +$88.6K | 0.07% | 257 |
|
|
2023
Q2 | $825K | Buy |
2,158
+279
| +15% | +$107K | 0.06% | 270 |
|
|
2023
Q1 | $651K | Buy |
1,879
+85
| +5% | +$29.5K | 0.06% | 297 |
|
|
2022
Q4 | $422K | Buy |
1,794
+157
| +10% | +$37K | 0.04% | 370 |
|
|
2022
Q3 | $403K | Buy |
1,637
+298
| +22% | +$73.4K | 0.05% | 332 |
|
|
2022
Q2 | $405K | Buy |
1,339
+75
| +6% | +$22.7K | 0.05% | 323 |
|
|
2022
Q1 | $519K | Buy |
1,264
+153
| +14% | +$62.8K | 0.06% | 300 |
|
|
2021
Q4 | $521K | Buy |
1,111
+358
| +48% | +$168K | 0.06% | 287 |
|
|
2021
Q3 | $320K | Buy |
753
+59
| +9% | +$25.1K | 0.05% | 335 |
|
|
2021
Q2 | $249K | Buy |
+694
| New | +$249K | 0.04% | 362 |
|